Expression of Toll-Like Receptors 2,4 and Nuclear Factor Kappa B in Mucosal Lesions of Human Otitis

Abstract

Objectives:

The objectives were to detect and compare the expression of toll-like receptors (TLRs) 2, 4 and nuclear factor kappa B in mucosal lesions of chronic otitis.

Methods:

Fifty-five tissue samples obtained from children and adults operated on for otitis were investigated by semiquantitative immunohistochemical methods using polyclonal antibodies for TLR 2, 4 and NFkB. Kruskal–Wallis, Mann–Whitney, and Kendall’s tau rank correlation tests were used.

Results:

Stronger expression of TLR2, 4 was found in inflamed mucosa than in the control for children and adults (TLR2: H = 23.86, P < .001; TLR4: H = 22.80, P < .001) (TLR2: H = 17.53, P < .001; TLR4: H = 11.99, P < .001); in cholesteatoma perimatrix compared to tubotympanic lesions in children (TLR2: H = 11.06, P = .004; TLR4: H = 10.61, P = .005) and adults (TLR2: H = 10.73, P = .013; TLR4: H = 9.65, P = .021). No differences were found in NFkB expression (H = 0.042, P = .99). Significant correlations were found for all pairs of molecules in cholesteatoma and tubotympanic mucosa of adults (TLR2, 4: P = .002, P < .001; TLR2-NfkB: P = .032, P = .021; TLR4-NFkB: P = .035, P = .0013), only TLR4-NFkB in tubotympanic otitis of children (P = .026).

Conclusions:

Toll-like receptors 2, 4 and NFkB mediate inflammation in cholesteatoma and mucosal lesions of tubotympanic otitis in children and adults. Significant correlations between all pairs of molecules in all samples were detected in adults, but only TLR4-NFkB in children.

Keywords

toll-like receptors nuclear factor kappa B otitis humans

Get full access to this article

View all access options for this article.

References

Shuto

Wang

, et al. Activation of NF-kappa B by nontypeable Hemophilus influenzae is mediated by toll-like receptor 2-TAK1-dependent NIK-IKK alpha/beta-I kappa B alpha and MKK3/6-p38 MAP kinase signaling pathways in epithelial cells. Proc Natl Acad Sci USA. 2001;98(15):8774-8779.

Moon

Woo

Lee

, et al. Toll-like receptor 2-dependent NF-kappa B activation is involved in nontypeable Haemophilus influenzae-induced monocyte chemotactic protein 1 up-regulation in the spiral ligament fibrocytes of the inner ear. Infect Immun. 2007;75(7):3361-3372.

Leichtle

Lai

Wollenberg

Wasserman

Ryan

. Innate signaling in otitis media: pathogenesis and recovery. Curr Allergy Asthma Rep. 2011;11(1):78-84.

Komori

Nakamura

Ping

, et al. Pneumococcal peptidoglycan-polysaccharides regulate toll-like receptor 2 in the mouse middle ear epithelial cells. Pediatr Res. 2011;69(2):101-105.

Fan

Frey

Malik

. TLR4 signaling induces TLR2 expression in endothelial cells via neutrophil NADPH oxidase. J Clin Invest. 2003;112(8):1234-1243.

Remer

Brcic

Sauter

Jungi

. Human monocytoid cells as a model to study toll-like receptor-mediated activation. J Immunol Methods. 2006;313(1-2):1-10.

Doyle

O’Neill

. Toll-like receptors: from the discovery of NFκB to new insights into transcriptional regulations in innate immunity. Biochem Pharmacol. 2006;72(9):1102-1113.

Okazaki

Sakon

Sasazuki

, et al. Phosphorylation of serine 276 is essential for p65 NF-kappaB subunit-dependent cellular responses. Biochem Biophys Res Commun. 2003;300(4):807-812.

Parker

Prince

Sabroe

. Translational mini-review series on toll-like receptors: networks regulated by toll-like receptors mediate innate and adaptive immunity. Clin Exp Immunol. 2007;147(2):199-207.

10.

O’Neill

. How Toll-like receptors signal: what we know and what we don’t know? Curr Opin Immunol. 2006;18(1):3-9.

11.

Drexler

Foxwell

. The role of Toll-like receptors in chronic inflammation. Int J Biochem Cell Biol. 2010;42(4):506-518.

12.

Lowrence

. The nuclear factor NF-kB pathway in inflammation. Old Spring Harb Perspect Biol. 2009;1(6):a001651

13.

Lawrence

Gilroy

. Chronic inflammation: a failure of resolution? Int J Exp Pathol. 2007;88(2):85-94.

14.

Hirai

Kariya

Okano

, et al. Expression of toll-like receptors in chronic otitis media and cholesteatoma. Int J Pediatr Otorhinolaryngol. 2013;77(5):674-676.

15.

Zhang

Huang

, et al. Differential expression of toll-like receptors in chronic suppurative otitis media and cholesteatoma. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2012;47(5):388-393.

16.

Hirano

Kodama

Fujita

Maeda

Suzuki

. Role of toll-like receptor 4 in innate immune responses in a mouse model of acute otitis media. FEMS Immunol Med Microbiol. 2007;49(1):75-83.

17.

Trunea

Zhengb

. Mouse models for human otitis media. Brain Res. 2009;1277:90-103.

18.

Han

, et al. Mutation in phex gene predisposes BALB/c-PhexHyp-Duk/Y mice to otitis media. PLOS ONE. 2012;7(9):e43010.

19.

Granath

Cardell

Uddman

Harder

. Altered toll- and nod-like receptor expression in human middle ear mucosa from patients with chronic middle ear disease [Letter to the editor]. J Infect. 2011;63(2):174-176.

20.

Ovesen

Barrett

. Nuclear factor-κB in middle ear epithelial cells: a methodological study using an ELISA. Acta Oto-laryngologica. 2003;123(2):306-309.

21.

Szczepanski

Witold

Janek

, et al. Toll-like receptors 2, 3 and 4 (TLR-2, TLR-3 and TLR-4) are expressed in the microenvironment of human acquired cholesteatoma. Eur Arch Otorhinolaryngol. 2006;263(7):603-607.

22.

Lee

Ryu

Jong

Yeo

. Clinical approaches for understanding the expression levels of pattern recognition receptors in otitis media with effusion. Clin Exp Otorhinolaryngol. 2011;4(4):163-167.

23.

Shin

Cha

Kim

Lee

Yeo

. IgA and differentiation-associated transcription factors in chronic otitis media with effusion. Clin Exp Otorhinolaryngol. 2009;2(3):131-135.

24.

Moon

Woo

Pan

Lee

Gellibolian

Lim

. Activation of NFkB with serine phosphorylation by otitis media pathogens in epithelial cells [Abstract]. FASEB J. 2008;22:826.4

25.

Hamajima

Komori

Preciado

, et al. The role of inhibitor of DNA-binding (Id1) in hyperproliferation of keratinocytes: the pathological basis for middle ear cholesteatoma derived from chronic otitis media. Cell Prolif. 2010;43(5):457-463.